Multiple Assemblies exist for SMTL entry 5u7l
PDE2 catalytic domain complexed with inhibitors; X-RAY DIFFRACTION 2.38 Å

	SMTL ID 5u7l.1 Ligands (3R)-1-{3-[5-(4-ethylphenyl)-1-methyl-1H-pyrazol-4-yl]-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-N,N-dimethylpyrrolidin-3-amine; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7l.2 Ligands (3R)-1-{3-[5-(4-ethylphenyl)-1-methyl-1H-pyrazol-4-yl]-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-N,N-dimethylpyrrolidin-3-amine; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer
	SMTL ID 5u7l.3 Ligands (3R)-1-{3-[5-(4-ethylphenyl)-1-methyl-1H-pyrazol-4-yl]-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-N,N-dimethylpyrrolidin-3-amine; ZINC ION; MAGNESIUM ION Polypeptides cGMP-dependent 3',5'-cyclic phosphodiesterase Oligo-state monomer